DTAB Recommends To Form Sub-Committee To Examine Requirement Of RMP For Sales Of Cough Syrups

New Delhi : The Drugs Technical Advisory Board (DTAB) has recommended formation of a sub-committee to examine aspects including the requirement of Registered Medical Practitioner (RMP) for sale of various cough syrups in the country.

A recent meeting of the DTAB made the recommendation while looking into a representation received from Mumbai-based USV Pvt Ltd to move its approved drug Dried Ivy Leaf Extract Cough Syrup, from prescription drug to the Schedule K of the Drugs and Cosmetics Rules, 1945.

USV has requested for marketing of approved drug “Dried Ivy Leaf Extract Cough Syrup” under Schedule K (Rule 123) and requested exemption from the “WARNING: “To be sold by retail on the prescription of a RMP only”

It has also submitted the proposal and a recommendation from the Subject Expert Committee for the consideration of the Board.

“DTAB deliberated the matter and recommended that a sub-committee should be constituted to examine the proposal and also to examine the requirement of RMP for sale of various cough syrups in the country,” concluded the Board.

The SEC, which advises the drug regulator on matters related to Pulmonary therapeutic segment, in its 60th meeting on June 7, 2022, recommended for exemption of the drug from ‘Warning’ label requirement for marketing of the cough syrup. It also opined that an opinion from a phytopharmaceutical expert may be obtained for further proceedings.

Prior to the recommendation, the company presented patient safety data, details of concentration of Saponin in the reduction and the details of countries in which the product is marketed, package insert and regulatory status before the committee.

USV sells Prospan brand of dried ivy leaf extract based cough syrup in the market. The company, in its website claims that the exclusive extract from the leaves is carefully made using a patented extraction process and backed by years of clinical research.

It may be noted that the decision to look into the requirement of RMP for the same of various cough syrups in the country comes at a time when there has been an increased focus on the quality of cough syrups manufactured and exported from the country.

Related Posts

  • Pharma
  • June 18, 2025
  • 87 views
Glenmark Pharma: FDA concludes inspection at US facility, issues five observations

Glenmark Pharmaceuticals said that the United States’ Food and Drug Administration (FDA) has concluded inspection of its manufacturing facility in Monroe, North Carolina. Glenmark Pharmaceuticals said that the United States’…

  • Pharma
  • June 18, 2025
  • 74 views
ED conducts searches across six States in drug trafficking case

The Enforcement Directorate on Tuesday conducted searches at 15 locations, including the premises of five pharmaceutical companies, across six States in connection with a drug trafficking case registered in Punjab.…

Leave a Reply

Your email address will not be published. Required fields are marked *

You Missed

Glenmark Pharma: FDA concludes inspection at US facility, issues five observations

Glenmark Pharma: FDA concludes inspection at US facility, issues five observations

ED conducts searches across six States in drug trafficking case

ED conducts searches across six States in drug trafficking case

Gurugram: Teen dies after ‘friendly’ blow to chest; hospital role under scanner

Gurugram: Teen dies after ‘friendly’ blow to chest; hospital role under scanner

Biocon launches Rs 4,500-crore QIP; to issue 11.6% of equity base

Biocon launches Rs 4,500-crore QIP; to issue 11.6% of equity base

Zydus Healthcare appoints Swati Dalal MD

Zydus Healthcare appoints Swati Dalal MD

Natco Pharma appoints Yarramshetty Krishna Rao as Senior Vice President – Operations at Mekaguda

Natco Pharma appoints Yarramshetty Krishna Rao as Senior Vice President – Operations at Mekaguda